COVID-19 vaccine clinical research

In 2022, Adapted Vaccines against Current Variants of COVID-19 Will be Launched in Bulgaria

In 2022, adapted vaccines according to current variants of the coronavirus are expected to be approved. Currently, the third dose uses vaccines that we have, but a combination is allowed - in the first and second dose of vector vaccine to be given an mRNA vaccine.

Bulgarian Health Ministry: Get Vaccinated, Covid Delta Variant Has No Mercy

 People who have no contraindications to vaccination and have not been vaccinated should promptly start and complete the recommended COVID-19 vaccination series, especially given the fast spreading Delta variant of the coronavirus, the Health Ministry here said Saturday, referring to recommendations issued by the European Medicines Agency (EMA) and the European Centre for Disease Prevention and

Prof. Mutafchiiski Had a Third Dose. When and in Which Groups is it Recommended?

It has been proven that a certain period after immunization, the protection decreases. Therefore, I did not hesitate, as with the "first needle", to put a "third."

This is the argument of the deputy of the Military Medical Academy (MMA) Prof. Ventsislav Mutafchiiski. The hospital said that he and 11 other colleagues had received an additional dose of COVID vaccine.

Almost 1,190 new coronavirus infections on Tuesday, ten deaths

Ljubljana – A total of 1,186 PCR tests returned positive on Tuesday or 20% of all tests, the National Institute of Public Health (NIJZ) said on Wednesday. The number of active cases in the country is estimated at 13,743. The number of patients in hospitals was up further, and ten Covid-19 patients died, the government said.

Third mRNA vax dose approved for adults 60 or over, healthcare workers

The National Commission on Vaccination announced today that it has approved the administration of a third dose of mRNA vaccines (Pfizer and Moderna) to individuals age 60 or older and to healthcare workers.

Greece has fully vaccinated 56 percent of the population and the rate remains low among citizens in the high-risk older age brackets.

Pages